天益医疗
(301097)
| 流通市值：13.79亿 | | | 总市值：28.43亿 |
| 流通股本：3959.04万 | | | 总股本：8160.94万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 338,262,037.04 | 163,867,248.73 | 575,755,706.89 | 387,051,372.64 |
| 营业总成本 | 331,733,313.67 | 152,555,298.22 | 545,671,644.66 | 358,533,795.24 |
| 其他经营收益 | | | | |
| 营业利润 | 1,913,191.8 | 11,197,865.88 | -922,960.56 | 23,027,699.52 |
| 利润总额 | 1,356,128.67 | 11,184,036.47 | -10,779,819.63 | 22,494,068.34 |
| 净利润 | 16,117,722.12 | 9,294,752.55 | -16,220,422.56 | 20,903,434.68 |
| 每股收益 | | | | |
| 其他综合收益 | -18,057,322.41 | -1,015,981.82 | 4,411,878.64 | 3,445,158.59 |
| 综合收益总额 | -1,939,600.29 | 8,278,770.73 | -11,808,543.92 | 24,348,593.27 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 929,396,316.42 | 953,162,061.73 | 928,953,162.25 | 984,170,929.23 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,252,341,494.56 | 1,217,585,837.09 | 1,137,580,187.44 | 1,086,311,472.83 |
| 资产总计 | 2,181,737,810.98 | 2,170,747,898.82 | 2,066,533,349.69 | 2,070,482,402.06 |
| 流动负债: | | | | |
| 流动负债合计 | 697,690,259.07 | 623,817,784.92 | 565,025,571.49 | 464,864,268.88 |
| 非流动负债: | | | | |
| 非流动负债合计 | 466,193,483.03 | 432,154,344.39 | 355,127,300.43 | 423,836,870.2 |
| 负债合计 | 1,163,883,742.1 | 1,055,972,129.31 | 920,152,871.92 | 888,701,139.08 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,017,854,068.88 | 1,114,775,769.51 | 1,146,380,477.77 | 1,181,781,262.98 |
| 股东权益合计 | 1,017,854,068.88 | 1,114,775,769.51 | 1,146,380,477.77 | 1,181,781,262.98 |
| 负债和股东权益合计 | 2,181,737,810.98 | 2,170,747,898.82 | 2,066,533,349.69 | 2,070,482,402.06 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 369,887,151.25 | 258,348,531.33 | 601,388,127.48 | 489,261,298.21 |
| 经营活动现金流出小计 | 379,552,592.49 | 217,346,298.16 | 506,264,002.28 | 455,512,592.25 |
| 经营活动产生的现金流量净额 | -9,665,441.24 | 41,002,233.17 | 95,124,125.2 | 33,748,705.96 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 577,215,526.51 | 270,615,455.98 | 1,408,385,899.12 | 975,422,315.9 |
| 投资活动现金流出小计 | 650,698,837.82 | 583,636,594.86 | 1,750,210,330.02 | 1,154,965,395.02 |
| 投资活动产生的现金流量净额 | -73,483,311.31 | -313,021,138.88 | -341,824,430.9 | -179,543,079.12 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 416,671,073.57 | 366,353,850.54 | 461,623,211.11 | 350,498,161.67 |
| 筹资活动现金流出小计 | 264,243,456.04 | 100,981,436.69 | 225,835,309.75 | 141,337,126.63 |
| 筹资活动产生的现金流量净额 | 152,427,617.53 | 265,372,413.85 | 235,787,901.36 | 209,161,035.04 |
| 汇率变动对现金及现金等价物的影响 | -21,211,385.06 | -8,418,538.83 | -13,512,545.92 | 1,681,014.77 |
| 现金及现金等价物净增加额 | 48,067,479.92 | -15,065,030.69 | -24,424,950.26 | 65,047,676.65 |
| 期末现金及现金等价物余额 | 328,459,744.54 | 265,327,233.93 | 280,392,264.62 | 369,864,891.53 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 48,067,479.92 | - | -24,424,950.26 | - |